During the past decade, National Taiwan University Hospital-Hsin-Chu Branch conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 2 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 2 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Taiwan University Hospital-Hsin-Chu Branch" #1 sponsor was "National Taiwan University Hospital Hsin-Chu Branch" with 16 trials, followed by "National Taiwan University Hospital" with 7 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Taiwan University Hospital-Hsin-Chu Branch" #1 collaborator was "E-DA Hospital" with 2 trials as a collaborator, "Baui Biotech Co., Ltd." with 1 trials as a collaborator, "Chiayi Christian Hospital" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Kaohsiung Medical University" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "National Taiwan University Hospital-Hsin-Chu Branch" are "Lung Cancer" (4 trials), "Arthritis, Psoriatic" (2 trials), "Atrial Fibrillation" (2 trials), "Hemodialysis Access Failure" (2 trials) and "Osteoporosis" (2 trials). Many other conditions were trialed in "National Taiwan University Hospital-Hsin-Chu Branch" in a lesser frequency.

Most popular intervention types in "National Taiwan University Hospital-Hsin-Chu Branch" are "Drug" (15 trials), "Device" (9 trials), "Procedure" (3 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Guselkumab" (2 trials), "Posthorax Thoraxbelt" (2 trials), "aCRT OFF" (2 trials) and "aCRT ON" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Taiwan University Hospital-Hsin-Chu Branch" are 36 trials for "All" genders.

Currently, there are NaN active trials in "National Taiwan University Hospital-Hsin-Chu Branch". undefined are not yet recruiting, 14 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in National Taiwan University Hospital-Hsin-Chu Branch, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Taiwan University Hospital-Hsin-Chu Branch, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 13 trials that are defined as “Not Applicable".

National Taiwan University Hospital-Hsin-Chu Branch has several departments that took part in Clinical trials: "National Taiwan University Hospital Hsin-Chu Branch Biomedical Park Hospital" - 2 trials